[Analysis of serious respiratory complications in PICU in children with measles]

Danqun Jin1, Jie Ding1, Jingmin Sun1

  • 1Pediatric Intensive Care Unit, Anhui Provincial Children's Hospital, Hefei 230051, China.

Abstract

Insights

Children with measles requiring intensive care face severe complications like acute respiratory distress syndrome and pneumothorax, leading to a high mortality risk. Prompt recognition and management are crucial for improving outcomes in these critical measles cases.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Measles is a highly contagious viral illness that can lead to severe complications, particularly in young children.
  • Intensive care unit (ICU) admission for measles indicates a critical illness with a high risk of adverse outcomes.

Purpose of the Study:

  • To characterize the serious complications and outcomes of pediatric patients with measles admitted to the ICU.
  • To identify risk factors associated with mortality and long-term sequelae in severe measles cases.

Main Methods:

  • Retrospective analysis of 17 pediatric cases with measles and serious complications admitted to the ICU.
  • Review of clinical characteristics, imaging findings, treatment, and prognosis.

Main Results:

  • All 17 patients required mechanical ventilation due to severe respiratory distress.
  • Common complications included acute respiratory distress syndrome (ARDS) in 14 cases and tension pneumothorax in 6 cases.
  • The mortality rate was 41% (7 deaths), with survivors experiencing various sequelae such as pneumothorax, bronchopleural fistula, and pulmonary fibrosis.

Conclusions:

  • Children with measles admitted to the ICU, especially those with ARDS and pneumothorax, have a high risk of death and poor prognosis.
  • Complications like laryngitis can lead to prolonged recovery and weaning difficulties.
  • Secondary bacterial infections are common in critically ill measles patients.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.3K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.2K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
5.2K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.6K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
681